Announce Date | 04/30/2025 |
EPS Normalized Actual | $1.23 (Beat by $0.03) |
EPS GAAP Actual | $1.23 (Beat by $0.03) |
Revenue Actual | $5.082B |
Revenue Surprise | Beat by $5082M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.19241 |
EPS GAAP Estimate | $1.19241 |
Revenue Estimate | $5.070972386B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 5.90585 | 13.85 | 5.76366 | 6.12915 | 6 |
Dec 2027 | 5.95731 | 13.73 | 5.75025 | 6.26009 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.1 | 1.1 | 5.082B | 6.38% | 5082M |
FQ3 2024 (Sep 2024) | 3.23 | 3.23 | 5.044B | 2.91% | 5044M |
FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 4.85B | -0.74% | 4850M |
FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 4.76B | -1.09% | 4760M |
FQ4 2023 (Dec 2023) | 1.12 | 1.12 | 4.758B | -1.7% | 4758M |
FQ3 2023 (Sep 2023) | 1.04 | 1.04 | 4.897B | 0.82% | 4897M |
FQ2 2023 (Jun 2023) | 0.92 | 0.92 | 4.886B | -0.41% | 4886M |
FQ1 2023 (Mar 2023) | 1.76 | 1.76 | 4.812B | 100% | 4812M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.19241
Consensus Revenue Estimates
5.070972386B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.52723 | -- | 1.51274 | 1.54686 | 8 |
FQ2 2027 (Jun 2027) | 1.50278 | -- | 1.48852 | 1.52209 | 5 |
FQ1 2027 (Mar 2027) | 1.4497 | -- | 1.43568 | 1.46806 | 5 |
FQ4 2026 (Oct 2026) | 1.42429 | -- | 1.40866 | 1.46235 | 5 |
FQ3 2026 (Jul 2026) | 1.30082 | -- | 1.28655 | 1.33558 | 5 |
FQ2 2026 (Jun 2026) | 1.29032 | -- | 1.27102 | 1.31337 | 5 |
FQ1 2026 (Mar 2026) | 1.28319 | -- | 1.264 | 1.30611 | 11 |
FQ4 2025 (Oct 2025) | 1.26907 | 13.32 | 1.25515 | 1.30298 | 11 |
FQ3 2025 (Jul 2025) | 1.19645 | -169.97 | 1.18332 | 1.22842 | 10 |
FQ2 2025 (Jun 2025) | 1.19241 | 4.4 | 1.17457 | 1.21371 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 6.14B | -- | 6.1B | 6.2B | 5 |
FQ2 2027 (Jun 2027) | 5.89B | -- | 5.85B | 5.95B | 5 |
FQ1 2027 (Mar 2027) | 5.69B | -- | 5.64B | 5.74B | 5 |
FQ4 2026 (Oct 2026) | 5.69B | -- | 5.65B | 5.81B | 10 |
FQ3 2026 (Jul 2026) | 5.49B | -- | 5.45B | 5.61B | 10 |
FQ2 2026 (Jun 2026) | 5.55B | -- | 5.48B | 5.62B | 10 |
FQ1 2026 (Mar 2026) | 5.31B | -- | 5.25B | 5.39B | 10 |
FQ4 2025 (Oct 2025) | 5.16B | 1.44 | 5.11B | 5.26B | 5 |
FQ3 2025 (Jul 2025) | 5.03B | -0.33 | 4.99B | 5.13B | 5 |
FQ2 2025 (Jun 2025) | 5.07B | 4.36 | 5.01B | 5.14B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.1 | 1.1 | 100% | |
FQ3 2024 (Sep 2024) | 3.23 | 3.23 | 100% | |
FQ2 2024 (Jun 2024) | 1.14 | 1.14 | 100% | |
FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 100% | |
FQ4 2023 (Dec 2023) | 1.12 | 1.12 | 100% | |
FQ3 2023 (Sep 2023) | 1.04 | 1.04 | 100% | |
FQ2 2023 (Jun 2023) | 0.92 | 0.92 | 100% | |
FQ1 2023 (Mar 2023) | 1.76 | 1.76 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $5.08B | $5082M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.04B | $5044M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.85B | $4850M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.76B | $4760M | 100% |
FQ4 2023 (Dec 2023) | $0B | $4.76B | $4758M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.9B | $4897M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.89B | $4886M | 100% |
FQ1 2023 (Mar 2023) | $0B | $4.81B | $4812M | 100% |